| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | 54.30 |
| 2 | Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. | J Clin Oncol | 2006 | 6.95 |
| 3 | Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. | J Hepatol | 2012 | 3.04 |
| 4 | Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. | Gastrointest Cancer Res | 2011 | 1.10 |
| 5 | Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses. | J Hepatol | 2012 | 1.01 |
| 6 | Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic. | J Gastrointestin Liver Dis | 2008 | 0.79 |